Strategies to establish the BE changing the physiological behavior [Study Per­for­mance]

posted by Mauricio Sampaio  – Brazil, 2016-06-29 08:47 (3295 d 16:25 ago) – Posting: # 16459
Views: 6,857

Dear members...

According draft guidance on hydrocortisone (Nonbinding Recommendations on Hydrocortisone) FDA recommends a 4 mg dose of dexamethasone administered 10 hours prior to drug administration as a pre-treatment to lower endogenous hydrocortisone levels. This procedure in bioequivalence studies is normal? Can I change the phisiological behavior to measure a principal analyte in appropriate biological fluid and determine the bioequivalence between two formulations?

Can I extrapolate this idea, in bioequivalence studies, to reduce the first pass effect using the vasodilator medicines* before the administration of drugs which are highly metabolized? To have a chance to mensure the parent compound (not metabolized) and to establish the bioequivalence result ?

* The use of vasodilator medicines increase the splenic blood flow and reduce the first pass effect
.

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,686 registered users;
88 visitors (0 registered, 88 guests [including 10 identified bots]).
Forum time: 01:12 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5